Diagnamed Holdings Corp. (CSE:DMED)
Canada flag Canada · Delayed Price · Currency is CAD
0.0350
0.00 (0.00%)
Mar 28, 2025, 3:51 PM EST

Diagnamed Holdings Income Statement

Millions CAD. Fiscal year is Oct - Sep.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Dec '24 Sep '24 Sep '23 Sep '22 Sep '21
Cost of Revenue
---0.020.02
Gross Profit
----0.02-0.02
Selling, General & Admin
0.330.430.810.410.47
Research & Development
0.250.250.350.560.2
Operating Expenses
0.630.671.181.110.67
Operating Income
-0.63-0.67-1.18-1.14-0.68
Interest & Investment Income
-0.010.01--
Currency Exchange Gain (Loss)
-0.030.010.020-
Other Non Operating Income (Expenses)
-0.07-0.07-0.08--
EBT Excluding Unusual Items
-0.73-0.72-1.23-1.13-0.68
Other Unusual Items
0.050.22-0.05--1.26
Pretax Income
-0.67-0.5-1.28-1.13-1.95
Net Income
-0.67-0.5-1.28-1.13-1.95
Net Income to Common
-0.67-0.5-1.28-1.13-1.95
Shares Outstanding (Basic)
8080787656
Shares Outstanding (Diluted)
8080787656
Shares Change (YoY)
1.37%2.38%2.81%36.38%-
EPS (Basic)
-0.01-0.01-0.02-0.01-0.03
EPS (Diluted)
-0.01-0.01-0.02-0.01-0.03
EBIT
-0.63-0.67-1.18-1.14-0.68
Source: S&P Global Market Intelligence. Standard template. Financial Sources.